The role of short chain fatty acids in appetite regulation and energy homeostasis.

Byrne CS, Chambers ES, Morrison DJ, Frost G. · 2015

Read The role of short chain fatty acids in appetite regulation and energy homeostasis. by Byrne CS, Chambers ES, Morrison DJ, Frost G. (2015) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc4564526.txt.

Introduction

C. S. Byrne, E. S. Chambers, D. J. Morrison, and G. Frost review gut-made fatty acids and appetite, in the International Journal of Obesity in 2015. Interest has grown in how the gut talks to the brain about hunger. Gut microbes ferment fiber and resistant starch that human enzymes cannot digest, releasing short chain fatty acids as their main product.

Eating fermentable carbohydrates, or taking these fatty acids directly, has been linked to leaner body composition, steadier blood sugar and fats, and lower colon cancer risk. Most studies, though, report effects tissue by tissue, leaving the whole-body story untold. The review connects the local gut effects to appetite control and energy balance across the body.

Catalog record

CREATORByrne CS, Chambers ES, Morrison DJ, Frost G.
YEAR2015
COLLECTIONPAPERS
FORMATTXT
FILE SIZE60 KB
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC4564526

Browse the full library · About the Tower of Babel

Full text

The opening of the work, from the library's hosted text:

The role of short chain fatty acids in appetite regulation and energy homeostasis By C S Byrne, E S Chambers, D J Morrison, G Frost Published in: International Journal of Obesity (2005) DOI: 10.1038/ijo.2015.84 ABSTRACT Abstract Over the last 20 years there has been an increasing interest in the influence of the gastrointestinal tract on appetite regulation. Much of the focus has been on the neuronal and hormonal relationship between the gastrointestinal tract and the brain. There is now mounting evidence that the colonic microbiota and their metabolic activity have a significant role in energy homeostasis. The supply of substrate to the colonic microbiota has a major impact on the microbial population and the metabolites they produce, particularly short chain fatty acids (SCFAs). SCFAs are produced when non-digestible carbohydrates, namely dietary fibres and resistant starch, undergo fermentation by the colonic microbiota. Both the consumption of fermentable carbohydrates and the administration of SCFAs have been reported to result in a wide range of health benefits including improvements in body composition, glucose homeostasis, blood lipid profiles and reduced body weight and colon cancer risk. However, published studies tend to report the effects that fermentable carbohydrates and SCFAs have on specific tissues and metabolic processes, and fail to explain how these local effects translate into systemic effects and the mitigation of disease risk. Moreover, studies tend to investigate SCFAs collectively and neglect to report the effects associated with individual SCFAs. Here, we bring together the recent evidence and suggest an overarching model for the effects of SCFAs on one of their beneficial aspects: appetite regulation and energy homeostasis. INTRODUCTION Obesity has become a global epidemic, with incidence rates of over 20% in the majority of western countries.1 It has been proposed that the current obesity epidemic may have been caused by a mismatch between the physiological mechanisms for maintaining energy balance, which evolved in response to ancestral diets, and the composition of the current western diet.2 Over the past several decades, the western diet has changed significantly with the popularity of ‘fast' and ‘convenience' foods rapidly increasing.3 Such foods are energy dense, have a low dietary fibre content and produce lower satiety and satiation signals than low-energy dense foods.4 This diet is markedly different to the historical low-energy dense, nutrient-poor diet that the human gut was adapted to over several millennia. Evidence suggests that for most of history the human lineage consumed more indigestible plant material, such as grasses, sedges and tubers, than is present in a typical western-style diet (>100 g per day dietary fibre compared with <15 g per day in the average modern-day diet), and is therefore likely to have contained a larger non-digestible component.5, 6 Some carbohydrates resist digestion in the upper gastrointestinal tract and reach the large bowel mainly intact where they are subject to fermentation by the resident bacteria. The human gut microbiota is composed of 1013 –1014 microorganisms, accounting for >1 kg of body weight.7, 8 The gut microbiota is continuing to emerge as a major determinant of obesity and its associated health complications.9, 10 However, as this topic is beyond the scope of the present review readers are referred to the excellent review by Holmes et al.11, which focuses on the composition and functional activities of the gut microbiota. The principle products of the bacterial fermentation of non-digestible carbohydrates in the gut are short chain fatty acids (SCFAs), heat and gases.12, 13, 14 The process of bacterial fermentation serves as an energy harvest system for undigested material, rescuing energy that cannot be absorbed in the small bowel, and is used as a major energy source for some species. For example, lowland gorillas derive ~57% of their metabolisable energy from SCFAs, compared with 1.2–10% in humans from the average western diet.15, 16, 17 The main SCFAs produced by bacterial fermentation are acetate, propionate and butyrate, and are present in the approximate molar ratio of 60:20:20.18 It has been demonstrated that the consumption of soluble fermentable carbohydrates (FCs) increases the caecel content of SCFAs in animal models.19, 20 The rate, ratio and extent of SCFA production, however, is a complex interplay between FC type, microbiome diversity and activity, and gut transit time.21, 22, 23, 24, 25 Supplementing the high-fat diet of rodents with soluble FCs has been shown to protect against body weight and fat mass gain.26, 27, 28 Futhermore, research suggests that adult rodents who consume a weaning diet high in prebiotic fibre are protected against body weight gain when challenged with a western-style diet high in fat and sucrose.29 However, research carried out by Track et al.30 suggests that the beneficial effects of FC consumption are specific to adolescent rodents. In addition to improvements in body composition, a number of research studies in humans have reported associations between the consumption of FCs and improvements in glucose homeostasis, insulin sensitivity and blood lipid profiles, however, these beneficial effects were not present in young healthy adults.31, 32, 33, 34, 35, 36 Although it is known that greater FC consumption increases colonic SCFA production resulting in a wide range of health benefits, further research is needed to fully elucidate the molecular mechanisms by which SCFA mediate these effects. Published research often focuses on single mechanisms to explain the positive physiological effects associated with gut-derived SCFAs. However, we hypothesise that the beneficial effects reported are not the result of the activity of a single metabolic process on a specific tissue, but are more likely to be the result of the stimulation of a number of mechanisms activated in parallel. Here we review recent findings in this field and propose an interconnected picture of how SCFAs may affect appetite regulation and energy homeostasis. MATERIALS AND METHODS A review of the literature was conducted in 2014 using PubMed databases, with the following search terms: ‘short chain fatty acids' AND dietary fiber(MeSH terms), ‘short chain fatty acids' AND obesity(MeSH terms), ‘short chain fatty acids' AND appetite(MeSH terms), ‘short chain fatty acids' AND energy intake(MeSH terms), ‘short chain fatty acids' AND energy expenditure(MeSH terms), ‘short chain fatty acids' AND microbiota(MeSH terms), ‘short chain fatty acids' AND (‘free fatty acid receptor 3' OR ‘GPR41' OR ‘GPCR41') and ‘short chain fatty acids' AND (‘free fatty acid receptor 2' OR ‘GPR43' OR ‘GPCR43'). Reviews and research studies in which immune function or cancer progression/prevention were the primary focus were excluded as these topics were deemed beyond the scope of this review. Papers identified from the search were analysed by two of the authors and papers that were not relevant were rejected as shown in Figure 1. In total, 104 papers were identified as containing relevant primary evidence. [Figure: Flowchart outlining the methods used for research paper selection.] SCFAs and free fatty acid receptor signalling In 2003, three independent research groups discovered that the orphan G-protein-coupled receptors, GPR43 and GPR41, were activated by SCFAs.37, 38, 39 These receptors have since been renamed free fatty acid receptor 2 and 3 (FFA2 and FFA3; formerly GPR43 and GPR41, respectively). Acetate and propionate are the most potent activators of FFA2, whereas FFA3 is activated in the affinity order propionate>butyrate⩾acetate.37, 38, 39 However, results of studies using animal models must be noted with caution owing to interspecies variability. Hudson et al.40

Read the complete text